IM Cannabis (IMCC) Competitors $2.51 +0.09 (+3.72%) Closing price 08/6/2025 03:59 PM EasternExtended Trading$3.50 +0.99 (+39.44%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMCC vs. XCUR, LTRN, ACRV, CGTX, GRCE, MURA, ZIVO, PLUR, STTK, and COEPShould you be buying IM Cannabis stock or one of its competitors? The main competitors of IM Cannabis include Exicure (XCUR), Lantern Pharma (LTRN), Acrivon Therapeutics (ACRV), Cognition Therapeutics (CGTX), Grace Therapeutics (GRCE), Mural Oncology (MURA), ZIVO Bioscience (ZIVO), Pluri (PLUR), Shattuck Labs (STTK), and Coeptis Therapeutics (COEP). These companies are all part of the "pharmaceutical products" industry. IM Cannabis vs. Its Competitors Exicure Lantern Pharma Acrivon Therapeutics Cognition Therapeutics Grace Therapeutics Mural Oncology ZIVO Bioscience Pluri Shattuck Labs Coeptis Therapeutics IM Cannabis (NASDAQ:IMCC) and Exicure (NASDAQ:XCUR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment. Which has preferable earnings and valuation, IMCC or XCUR? IM Cannabis has higher revenue and earnings than Exicure. IM Cannabis is trading at a lower price-to-earnings ratio than Exicure, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIM Cannabis$39.44M0.26-$7.72M-$0.64-3.92Exicure$500K97.20-$9.70M-$3.82-2.01 Does the media prefer IMCC or XCUR? In the previous week, Exicure had 3 more articles in the media than IM Cannabis. MarketBeat recorded 5 mentions for Exicure and 2 mentions for IM Cannabis. IM Cannabis' average media sentiment score of 0.00 beat Exicure's score of 0.00 indicating that IM Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IM Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Exicure 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is IMCC or XCUR more profitable? Exicure has a net margin of 0.00% compared to IM Cannabis' net margin of -9.10%. IM Cannabis' return on equity of -122.96% beat Exicure's return on equity.Company Net Margins Return on Equity Return on Assets IM Cannabis-9.10% -122.96% -11.69% Exicure N/A -219.60%-82.03% Do insiders & institutionals have more ownership in IMCC or XCUR? 7.7% of IM Cannabis shares are owned by institutional investors. Comparatively, 42.8% of Exicure shares are owned by institutional investors. 5.9% of IM Cannabis shares are owned by company insiders. Comparatively, 3.9% of Exicure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk & volatility, IMCC or XCUR? IM Cannabis has a beta of 2.2, meaning that its share price is 120% more volatile than the S&P 500. Comparatively, Exicure has a beta of 3.67, meaning that its share price is 267% more volatile than the S&P 500. SummaryIM Cannabis beats Exicure on 7 of the 13 factors compared between the two stocks. Get IM Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IMCC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IMCC vs. The Competition Export to ExcelMetricIM CannabisMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.79M$10.56B$5.56B$9.47BDividend YieldN/A1.99%4.31%4.13%P/E Ratio-3.9219.3629.3723.99Price / Sales0.2626.10444.2396.64Price / CashN/A22.0635.8458.51Price / Book2.443.558.085.58Net Income-$7.72M$211.77M$3.26B$265.35M7 Day Performance-4.20%1.43%0.45%-0.07%1 Month Performance-23.94%4.22%4.82%1.76%1 Year Performance-17.97%-9.48%30.27%25.39% IM Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IMCCIM Cannabis0.2504 of 5 stars$2.51+3.7%N/A-17.2%$9.79M$39.44M-3.92340Upcoming EarningsGap UpXCURExicure0.8969 of 5 stars$6.63-8.2%N/A+1,108.2%$41.89MN/A-1.7450Positive NewsUpcoming EarningsGap DownLTRNLantern Pharma2.3005 of 5 stars$3.87-3.5%$25.00+546.0%+43.2%$41.74MN/A-2.1020News CoverageShort Interest ↑ACRVAcrivon Therapeutics2.8083 of 5 stars$1.33-7.0%$17.71+1,231.9%-82.1%$41.70MN/A-0.6058Upcoming EarningsCGTXCognition Therapeutics2.385 of 5 stars$0.67-6.3%$2.83+322.8%+10.2%$41.55MN/A-0.9120Upcoming EarningsGap DownGRCEGrace TherapeuticsN/A$2.98-1.7%$12.00+302.7%N/A$41.21MN/A-3.35N/APositive NewsUpcoming EarningsMURAMural Oncology2.7017 of 5 stars$2.38-1.2%$12.00+404.2%-47.0%$41.10MN/A-0.31119Earnings ReportUpcoming EarningsZIVOZIVO BioscienceN/A$10.70-3.2%N/A+64.6%$40.84M$15.85K-2.1910Upcoming EarningsGap UpPLURPluri2.077 of 5 stars$5.09-5.4%$12.00+135.8%-9.6%$40.06M$330K-0.92150Positive NewsSTTKShattuck Labs3.1538 of 5 stars$0.84+1.7%$7.50+797.9%-73.5%$40.01M$4.61M-0.60100News CoverageGap UpCOEPCoeptis TherapeuticsN/A$11.24-6.3%N/A+163.3%$39.45MN/A-1.942Positive News Related Companies and Tools Related Companies XCUR Competitors LTRN Competitors ACRV Competitors CGTX Competitors GRCE Competitors MURA Competitors ZIVO Competitors PLUR Competitors STTK Competitors COEP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IMCC) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMCC Stock Alerts